Amanote Research
Register
Sign In
Prm44 - Differentiating Discount Rates in Cost-Effectiveness Evaluations in the Context of Gene Therapies.
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2167
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
E Clay
M Pochopien
S Aballea
M Toumi
Publisher
Elsevier BV
Related search
Considerations About the Effectiveness and Cost Effectiveness of Therapies in the Treatment of Hyperphosphataemia
Health Economics Review
Health Policy
Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
PLoS Neglected Tropical Diseases
Pharmacology
Public Health
Environmental
Toxicology
Infectious Diseases
Pharmaceutics
Occupational Health
Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome
Annals of Internal Medicine
Internal Medicine
Medicine
Cost-Effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Archives of Internal Medicine
PSS14 Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb65 - The Cost-Effectiveness of Metformin in Pre-Diabetics: A Systematic Literature Review of Health Economic Evaluations
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Buyout Activity: The Impact of Aggregate Discount Rates
SSRN Electronic Journal
Oil Producing Countries' Discount Rates
Resources and Energy
Systematic Review of Utility Values Used in the Pharmacoeconomic Evaluations for Schizophrenia: Implications on Cost-Effectiveness Results
Journal of Market Access & Health Policy
